Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Taru Muranen
Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
Cancer Cell
Cancer Research
Oncology
Cell Biology
mTORC1 Inhibition Is Required for Sensitivity to PI3K P110 Inhibitors in PIK3CA-Mutant Breast Cancer
Science Translational Medicine
Medicine
Related publications
Approaching Resistance to Targeted Inhibition of PI3K in Breast Cancer
Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer
Cancer Discovery
Oncology
BxPC3 Pancreatic Cancer Cells Express a Truncated Smad4 Protein Upon PI3K and mTOR Inhibition
Oncology Letters
Cancer Research
Oncology
Honokiol-Mediated Inhibition of PI3K/mTOR Pathway
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology
Dual PI3K/mTOR Inhibition in Colorectal Cancers withAPCandPIK3CAMutations
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Vertical Inhibition of the PI3K/Akt/mTOR Pathway Is Synergistic in Breast Cancer
Oncogenesis
Cancer Research
Molecular Biology
In Vitro Effects of PI3K/mTOR Inhibition in Canine Hemangiosarcoma
PLoS ONE
Multidisciplinary
BEZ235 Impairs Gastric Cancer Growth by Inhibition of PI3K/mTOR in Vitro and in Vivo
BMC Pharmacology
Activation of WNT/β-catenin Signaling Results in Resistance to a Dual PI3K/mTOR Inhibitor in Colorectal Cancer Cells Harboring PIK3CA Mutations
International Journal of Cancer
Cancer Research
Oncology